These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 1348448

  • 21. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin.
    Kapoor R, Slade DL, Fujimori A, Pommier Y, Harker WG.
    Oncol Res; 1995; 7(2):83-95. PubMed ID: 7579731
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.
    Erlichman C, Boerner SA, Hallgren CG, Spieker R, Wang XY, James CD, Scheffer GL, Maliepaard M, Ross DD, Bible KC, Kaufmann SH.
    Cancer Res; 2001 Jan 15; 61(2):739-48. PubMed ID: 11212277
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Amine oxidase, spermine, and hyperthermia induce cytotoxicity in P-glycoprotein overexpressing multidrug resistant Chinese hamster ovary cells.
    Lord-Fontaine S, Agostinelli E, Przybytkowski E, Averill-Bates DA.
    Biochem Cell Biol; 2001 Jan 15; 79(2):165-75. PubMed ID: 11310564
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells.
    Kaufmann SH, Svingen PA, Gore SD, Armstrong DK, Cheng YC, Rowinsky EK.
    Blood; 1997 Mar 15; 89(6):2098-104. PubMed ID: 9058732
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.
    Sorensen M, Sehested M, Jensen PB.
    Br J Cancer; 1995 Aug 15; 72(2):399-404. PubMed ID: 7640225
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro.
    Ma J, Maliepaard M, Nooter K, Boersma AW, Verweij J, Stoter G, Schellens JH.
    Cancer Chemother Pharmacol; 1998 Aug 15; 41(4):307-16. PubMed ID: 9488600
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.
    Kaufmann SH, Peereboom D, Buckwalter CA, Svingen PA, Grochow LB, Donehower RC, Rowinsky EK.
    J Natl Cancer Inst; 1996 Jun 05; 88(11):734-41. PubMed ID: 8637027
    [Abstract] [Full Text] [Related]

  • 35. Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein-overexpressing cell lines.
    Hoki Y, Fujimori A, Pommier Y.
    Cancer Chemother Pharmacol; 1997 Jun 05; 40(5):433-8. PubMed ID: 9272121
    [Abstract] [Full Text] [Related]

  • 36. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
    Sosinski J, Thakar JH, Germain GS, Dias P, Harwood FC, Kuttesch JF, Houghton PJ.
    Mol Pharmacol; 1994 May 05; 45(5):962-70. PubMed ID: 7910660
    [Abstract] [Full Text] [Related]

  • 37. Topotecan is a substrate for multidrug resistance associated protein 4.
    Tian Q, Zhang J, Chan SY, Tan TM, Duan W, Huang M, Zhu YZ, Chan E, Yu Q, Nie YQ, Ho PC, Li Q, Ng KY, Yang HY, Wei H, Bian JS, Zhou SF.
    Curr Drug Metab; 2006 Jan 05; 7(1):105-18. PubMed ID: 16454695
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
    Kamath N, Grabowski D, Ford J, Kerrigan D, Pommier Y, Ganapathi R.
    Biochem Pharmacol; 1992 Sep 01; 44(5):937-45. PubMed ID: 1356339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.